From the makers of 
Track & Manage All Of Your Investments
Try It Now!
| |||||||||
CollaGenex Pharmaceuticals 8-K 2010 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 6, 2010 (April 1, 2010)
ARTISTRY PUBLICATIONS, INC.
(Exact name of registrant as specified in Charter)
239 Jianxin Road, Jiangbei District,
Chongqing, PRC 400000 (Address of Principal Executive Offices) (86) 023-67755514
(Issuer Telephone Number) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
Forward Looking Statements
This Form 8-K and other reports filed by Artistry Publications, Inc. (the “Registrant”) from
time to time with the Securities and Exchange Commission (collectively the “Filings”) contain
forward looking statements and information that are based upon beliefs of, and information
currently available to, the Registrant’s management as well as estimates and assumptions made by
the Registrant’s management. When used in the Filings the words “anticipate”, “believe”,
“estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar
expressions as they relate to the Registrant or the Registrant’s management identify forward
looking statements. Such statements reflect the current view of the Registrant with respect to
future events and are subject to risks, uncertainties, assumptions and other factors relating to
the Registrant’s industry, operations and results of operations and any businesses that may be
acquired by the Registrant. Should one or more of these risks or uncertainties materialize, or
should the underlying assumptions prove incorrect, actual results may differ significantly from
those anticipated, believed, estimated, expected, intended or planned.
Although Registrant believes that the expectations reflected in the forward looking statements
are reasonable, Registrant cannot guarantee future results, levels of activity, performance or
achievements. Except as required by applicable law, including the securities laws of the United
States, the Registrant does not intend to update any of the forward-looking statements to conform
these statements to actual results.
In this Form 8-K, references to “we,” “our,” “us,” “Company,” “Artistry” or the “Registrant”
refer to Artistry Publications, Inc., a Delaware corporation.
Appointment of Independent Directors
Effective April 1, 2010, the Board of Directors (“Board”) of the Registrant appointed the
following persons as directors of the Registrant, and effectively increased the number of directors
on the Board to six:
Based upon information submitted to the Board by Mr. Rudolph and Mr. Zhang, the Board has
determined that Mr. Rudolph and Mr. Zhang are each “independent” under the listing standards of
both the American Stock Exchange and the NASD Marketplace Rules. None of the appointees has
participated in the preparation of the Registrant’s financial statements or any current subsidiary
at any time during the past three years and each of them are able to read and understand
fundamental financial statements.
Agreements with Independent Directors
Mr. Rudolph and Mr. Zhang have each have executed and delivered a director offer letter, a
form of which is included with this Form 8-K as Exhibit 10.1. Under the terms of the agreements,
Mr. Rudolph and Mr. Zhang shall be entitled to the annual compensation of 12,500 shares of the
Company’s restricted stock.
About the Independent Directors
Mr. Michael Rudolph also serves as the founder, chief financial officer and managing member of
Viking Asset Management, LLC and an investment adviser to Longview Fund, LP and Longview Fund
International, LTD. (BVI), and has held such positions from January 2001 to the present. From July
1995 to December 2000, Mr. Rudolph established and acted as president of The Edgehill Group, Inc.
From January 1978 to June 1995, Mr. Rudolph held various senior management positions with Charles
Schwab’s Institutional Trading Division, Bank of America and Wells Fargo Bank. Mr. Rudolph has
also served on several board of directors, including ElectroSource, LLC and the Stanford University
Medical Center Stroke Advisory Board. Mr. Rudolph has qualified
for registration with the National Association of Securities Dealers as an investment advisor
since 2001. Mr. Rudolph received his Bachelor’s degree in Biochemistry from Purdue University in
1973 and a Master of Business Administration degree from Washington University in 1975.
2
Mr. Lihua Zhang also serves as the chairman of Songyuan Hydropower Plant, Bo Gong Ken
Hydropower Plant and Huaxi Hydropower Plant and has invested a total of RMB One Hundred Million in
building these three plants from 1998 to present. In addition to serving as chairman to these
three plants, Mr. Zhang is also responsible for investment, design and construction of such plants.
Mr. Zhang also serves as vice chairman of Zhejiang Commercial Association and has held such
position from 2006 to the present. Mr. Zhang is responsible for public relations between the
Zhejiang Commercial Association and other government agencies in other provinces, including Taiwan
and Hong Kong. Mr. Zhang also has served as a member of Political Consultant Conference in Songxi,
Fujiang province from 2006 to present. He has directly assisted the local government in attracting
a large number of enterprises, and these enterprises have in turn contributed to local government
tax revenue and resulted in local job creations. Mr. Zhang worked as a manager at the Yuan Kou
Reservoir from 1980 and 1990, and during this decade, Mr. Zhang constructed more than five
hydropower plans and obtained the certificate of senior hydropower engineer. Mr. Zhang received
his professional degree from Hangzhou Water Resources and Hydropower Professional School in 1980.
The independent directors have no family relationships with any of the current directors,
executive officers or persons nominated or appointed to become directors or executive officers.
There are no related party transactions to report involving the independent directors. The
independent directors do not have any material plan, contract or arrangement with the Registrant.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: April 6, 2010
4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
